Atai Life Sciences N.V.
ATAI
$4.76
-$0.07-1.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.91% | 32.16% | -48.21% | 54.14% | -114.55% |
| Total Depreciation and Amortization | 5.09% | -4.00% | 171.08% | 1.22% | -1.20% |
| Total Amortization of Deferred Charges | -81.88% | -20.74% | 43.51% | 33.67% | 0.00% |
| Total Other Non-Cash Items | -43.91% | -45.56% | 87.31% | -74.33% | 323.76% |
| Change in Net Operating Assets | 551.01% | 57.15% | -33.12% | -205.24% | 157.44% |
| Cash from Operations | 21.00% | 26.57% | -25.61% | -19.18% | 28.11% |
| Capital Expenditure | 87.52% | -16,866.67% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 199.15% | -261.04% | -75.01% | 52.38% | 42.11% |
| Cash from Investing | 188.83% | -267.90% | -73.59% | 52.38% | 42.11% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -67.39% | 38,970.78% | 180.00% | -83.13% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2,003.72% | -- | 100.00% | -- | -- |
| Cash from Financing | -86.99% | 38,604.55% | -96.85% | 1,401.23% | -- |
| Foreign Exchange rate Adjustments | 543.75% | -73.98% | -48.10% | 259.09% | 203.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 200.00% |
| Net Change in Cash | -88.13% | 276.32% | -264.23% | 2,181.12% | 104.17% |